Countdown to FMC Technologies (FTI) Q4 Earnings: Wall Street Forecasts for Key Metrics

16.02.26 15:15 Uhr

Werte in diesem Artikel
Aktien

14,43 EUR -0,56 EUR -3,70%

38,70 EUR 0,10 EUR 0,26%

61,33 EUR 1,35 EUR 2,25%

Indizes

PKT PKT

1.978,4 PKT -10,8 PKT -0,54%

2.039,6 PKT -11,5 PKT -0,56%

23.168,1 PKT -130,8 PKT -0,56%

8.634,5 PKT -67,5 PKT -0,78%

1.814,0 PKT -25,7 PKT -1,40%

2.975,3 PKT 0,8 PKT 0,03%

2.143,9 PKT 0,6 PKT 0,03%

219,4 PKT 0,3 PKT 0,14%

609,5 PKT -2,7 PKT -0,44%

12.265,4 PKT -73,6 PKT -0,60%

23.213,0 PKT -95,0 PKT -0,41%

23.146,7 PKT -107,5 PKT -0,46%

8.944,7 PKT -54,0 PKT -0,60%

16.328,5 PKT 0,0 PKT 0,00%

1.854,4 PKT -8,4 PKT -0,45%

Wall Street analysts forecast that FMC Technologies (FTI) will report quarterly earnings of $0.51 per share in its upcoming release, pointing to a year-over-year decline of 5.6%. It is anticipated that revenues will amount to $2.55 billion, exhibiting an increase of 7.6% compared to the year-ago quarter.The current level reflects an upward revision of 0.4% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.Given this perspective, it's time to examine the average forecasts of specific FMC Technologies metrics that are routinely monitored and predicted by Wall Street analysts.The consensus among analysts is that 'Revenue- Subsea Technologies' will reach $2.23 billion. The estimate suggests a change of +8.7% year over year.Based on the collective assessment of analysts, 'Revenue- Surface Technologies' should arrive at $322.00 million. The estimate points to a change of +0.8% from the year-ago quarter.Analysts forecast 'Revenue- Lease' to reach $71.31 million. The estimate indicates a year-over-year change of +24%.Analysts expect 'Revenue- Product' to come in at $922.80 million. The estimate indicates a change of +8.3% from the prior-year quarter.The combined assessment of analysts suggests that 'Revenue By Geography- Surface Technologies - Europe and Central Asia' will likely reach $33.62 million. The estimate indicates a change of +13.2% from the prior-year quarter.The consensus estimate for 'Revenue By Geography- Surface Technologies - Africa' stands at $15.95 million. The estimate indicates a change of +24.6% from the prior-year quarter.Analysts' assessment points toward 'Revenue By Geography- Surface Technologies- North America' reaching $105.63 million. The estimate indicates a year-over-year change of -1.6%.According to the collective judgment of analysts, 'Revenue By Geography- Surface Technologies - Middle East' should come in at $118.75 million. The estimate indicates a change of -5% from the prior-year quarter.Analysts predict that the 'Inbound Orders - Subsea Technologies' will reach $2.45 billion. The estimate compares to the year-ago value of $2.70 billion.The average prediction of analysts places 'Order Backlog - Subsea Technologies' at $16.31 billion. Compared to the present estimate, the company reported $13.52 billion in the same quarter last year.It is projected by analysts that the 'Order Backlog - Total' will reach $17.06 billion. The estimate compares to the year-ago value of $14.38 billion.The collective assessment of analysts points to an estimated 'Order Backlog - Surface Technologies' of $728.81 million. The estimate is in contrast to the year-ago figure of $858.20 million. View all Key Company Metrics for FMC Technologies here>>> Over the past month, shares of FMC Technologies have returned +17.6% versus the Zacks S&P 500 composite's -1.7% change. Currently, FTI carries a Zacks Rank #2 (Buy), suggesting that it may outperform. the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .Quantum Computing Stocks Set To SoarArtificial intelligence has already reshaped the investment landscape, and its convergence with quantum computing could lead to the most significant wealth-building opportunities of our time.Today, you have a chance to position your portfolio at the forefront of this technological revolution. In our urgent special report, Beyond AI: The Quantum Leap in Computing Power, you'll discover the little-known stocks we believe will win the quantum computing race and deliver massive gains to early investors.Access the Report Free Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report TechnipFMC plc (FTI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: FMC und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Quelle: Zacks

Nachrichten zu Fresenius Medical Care (FMC) St.

Analysen zu Fresenius Medical Care (FMC) St.

DatumRatingAnalyst
13.03.2026Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
13.03.2026Fresenius Medical Care (FMC) St KaufenDZ BANK
12.03.2026Fresenius Medical Care (FMC) St Equal WeightBarclays Capital
10.03.2026Fresenius Medical Care (FMC) St SellUBS AG
02.03.2026Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
DatumRatingAnalyst
13.03.2026Fresenius Medical Care (FMC) St KaufenDZ BANK
03.12.2025Fresenius Medical Care (FMC) St BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
07.11.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
05.11.2025Fresenius Medical Care (FMC) St KaufenDZ BANK
15.08.2025Fresenius Medical Care (FMC) St KaufenDZ BANK
DatumRatingAnalyst
12.03.2026Fresenius Medical Care (FMC) St Equal WeightBarclays Capital
02.03.2026Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
27.02.2026Fresenius Medical Care (FMC) St Equal WeightBarclays Capital
25.02.2026Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
24.02.2026Fresenius Medical Care (FMC) St Equal WeightBarclays Capital
DatumRatingAnalyst
13.03.2026Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
10.03.2026Fresenius Medical Care (FMC) St SellUBS AG
02.03.2026Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.
25.02.2026Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
24.02.2026Fresenius Medical Care (FMC) St SellUBS AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Fresenius Medical Care (FMC) St. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen